Richard A. Larson to Receptors, Thrombopoietin
This is a "connection" page, showing publications Richard A. Larson has written about Receptors, Thrombopoietin.
Connection Strength
0.037
-
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy. Br J Haematol. 2017 09; 178(6):906-913.
Score: 0.037